ZVRA Earnings

Quarterly EPS
$-0.01
Q3 2025
$-0.01
Q3 2025
$0.22
Q4 2025
$0.22
Q4 2025
$0.62
Q1 2026
$0.62
Q1 2026
$0.14
Q2 2026
$0.14
Q2 2026
Latest Revenue39.7M
Latest Net Income8.8M
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026$0.1439.7M8.8M+16.2%-36.4%
Q2 2026$0.1439.7M8.8M+16.2%-36.4%
Q1 2026$0.6236.2M37.9M+39.0%+6,300.0%
Q1 2026$0.6236.2M37.9M+39.0%+6,300.0%
Q4 2025$0.2234.1M12.2M+31.9%-82.3%
Q4 2025$0.2234.1M12.2M+31.9%-82.3%
Q3 2025-$0.0126.1M-544000+27.8%+83.3%
Q3 2025-$0.0126.1M-544000+27.8%+83.3%
Q2 2025$1.2425.9M74.7M
Q2 2025$1.2425.9M74.7M
Q1 2025-$0.0620.4M-3099000
Q1 2025-$0.0620.4M-3099000
Zevra Therapeutics (ZVRA) — Earnings